Pacific Biosciences
PACB
PACB
272 hedge funds and large institutions have $2.2B invested in Pacific Biosciences in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 91 increasing their positions, 86 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 270 → 272 (+2)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
35% less capital invested
Capital invested by funds: $3.37B → $2.2B (-$1.18B)
Holders
272
Holding in Top 10
4
Calls
$101M
Puts
$24.8M
Top Buyers
| 1 | +$38M | |
| 2 | +$26.6M | |
| 3 | +$22M | |
| 4 |
Bank of New York Mellon
New York
|
+$21M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$15.7M |
Top Sellers
| 1 | -$34M | |
| 2 | -$27.6M | |
| 3 | -$13.3M | |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$13.2M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$9.95M |